INGN — Inogen Inc
NASDAQ · Healthcare · Medical Devices
$5.38
+$0.04 (+0.84%)
Inogen Inc (INGN) is a medical devices company listed on NASDAQ. It is led by Kevin R. M. Smith, based in 500 Cummings Center, Beverly, MA, United States, 01915, with about 753 employees. Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.
Latest reported INGN revenue for 2025-09-30 was $92.4M. Net income was -$5.3M. Revenue was up 0.1% from 2025-06-30 to 2025-09-30. INGN currently screens at market cap $173.5M.
Use this INGN page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the INGN quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the INGN SEC filings page. Lician reads the product cache first so this HTML stays unique to Inogen Inc even when a live quote feed is slow.
About Inogen Inc
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.
INGN Key Statistics
Market Cap
$173.55M
Volume
333,323
Previous Close
$5.61
Day Range
$5.50 – $5.66
EPS
-$1.52
Revenue
$335.70M
Net Income
-$35.89M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+6.4%
Profit Margin
-10.7%
Employees
753
INGN Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $335.70M | $315.66M | $377.24M | $358.00M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$35.89M | -$102.45M | -$83.77M | -$6.33M |
| EPS (Diluted) | -$1.52 | -$4.42 | -$3.67 | -$0.28 |
Total Assets
$296.19M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$113.80M
Operating Cash Flow
$5.91M
Free Cash Flow
$0.00
Inogen Inc Company Information
- President, CEO & Director
- Kevin R. M. Smith
- Headquarters
- 500 Cummings Center, Beverly, MA, United States, 01915
- Website
- www.provider.inogen.com
- Phone
- 805 562 0500
- IPO / Founded
- 2014-02-14
- Sector
- Healthcare
- Industry
- Medical Devices